أرسل هذا في رسالة قصيرة: Discovery of FLT3-ITD Inhibitor Clifutinib: A Novel Biphenylacetylene Urea Derivative in Clinical Trials for the Treatment of Relapsed/Refractory FLT3-ITD<sup>+</sup> Acute Myeloid Leukemia